Baxter Wins Bid To Compel FDA Testimony In Plasma MDL

Law360, Los Angeles (September 16, 2013, 9:42 PM EDT) -- Baxter International Inc. won a bid to get a Food and Drug Administration official to testify in multidistrict litigation in which a class of hospitals allege the company and other plasma therapy providers conspired to fix prices, according to an order in D.C. federal court Monday.

U.S. District Judge Rudolph Contreras ordered Dr. Jay Epstein to spend seven hours testifying in the suit, in which a group of hospitals contend Baxter and its rivals teamed up to keep the price of plasma therapy artificially high....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.